Nuvation Bio Inc. (NUVB) vs Septerna, Inc. (SEPN)
- Nuvation Bio Inc. NUVB 4.45 −6.32%
- Septerna, Inc. SEPN 36.05 −3.74%
Nuvation Bio Inc. and Septerna, Inc. are both Biotechnology companies. Nuvation Bio Inc. and Septerna, Inc. are of similar size ($1.8B and $1.7B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against 1,083.6%. Septerna, Inc. has the higher net margin (−24.5% vs −88.2%) and the lower return on invested capital (−189.0% vs 0.00%). Across the 17 metrics below, Septerna, Inc. leads on 12 and Nuvation Bio Inc. on 5.
Valuation
Profitability
| Metric | NUVB | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | 88.18% | 100.00% | 65.16% |
| Operating margin | (81.00%) | (44.04%) | 0.00% |
| Net margin | (88.19%) | (24.51%) | 0.00% |
| Free cash flow margin | (71.17%) | 118.93% | 0.00% |
| Return on equity | (47.81%) | (6.34%) | (56.36%) |
| Return on assets | (21.53%) | (4.94%) | (48.04%) |
| Return on invested capital | 0.00% | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack